Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion type Assertion NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_head.
- NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion description "[We identified additional molecular aberrations in 24/27 (89%) patients with advanced SM (SM-AHNMD, 5/5; aggressive SM/mast cell leukemia, 19/22) whereas only 3/12 (25%) indolent SM/smoldering SM patients carried one additional mutation each (U2AF1, SETBP1, CBL) (P < .001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_provenance.
- NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion evidence source_evidence_literature NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_provenance.
- NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion SIO_000772 23958953 NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_provenance.
- NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion wasDerivedFrom befree-20140225 NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_provenance.
- NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_assertion wasGeneratedBy ECO_0000203 NP939471.RAzxHtvI3bccewY2nbs2u7XLtrwBhzbgC-jOyrhmUuilA130_provenance.